Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report
- 1 December 2017
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 70 (6) , 859-868
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPSKidney International, 2013
- A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk ScoreJournal of the American Heart Association, 2013
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney DiseaseNew England Journal of Medicine, 2012
- Effectiveness and Safety of Warfarin Initiation in Older Hemodialysis Patients with Incident Atrial FibrillationClinical Journal of the American Society of Nephrology, 2011
- The Increasing Prevalence of Atrial Fibrillation among Hemodialysis PatientsJournal of the American Society of Nephrology, 2011
- Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial FibrillationJournal of the American Society of Nephrology, 2009
- Cerebrovascular Disease Incidence, Characteristics, and Outcomes in Patients Initiating Dialysis: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) StudyAmerican Journal of Kidney Diseases, 2009
- Kidney Function Influences Warfarin Responsiveness and Hemorrhagic ComplicationsJournal of the American Society of Nephrology, 2009
- Cognitive Impairment in the Aging Dialysis and Chronic Kidney Disease Populations: An Occult BurdenAdvances in Chronic Kidney Disease, 2008
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006